NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

Horizon Pharma Plc said it would pay pharmacy benefit manager Express Scripts Holding $65 million to settle litigation related to after-market rebates for three of its medicines. Express Scripts, the largest manager of U.S. drug benefits, in November sued Horizon for a breach of contract, seeking $166.2 million in rebates…

news

Alcobra Ltd's market value more than halved on Thursday, a day after the company said the U.S. Food and Drug Administration had placed a hold on its lead experimental drug. Shares of the Israel-based company fell as much as 58 percent to a record low of $1.95. The hold affects…

news

Gabather AB Says has signed a consortium agreement for clinical development of its drug candidate GT-002 together with partner companies Pharmaterials, Smerud and CRST. Cooperation starts in October and lasts until Phase 2a or a total of three years. The agreement gives a net contribution from local EU authorities to…

news

Sensorion selects new drug candidate, SENS-401, to treat vestibular and auditory disorders associated with inner ear lesions. SENS-401 will also strengthen sensorion's intellectual property portfolio, and company has filed new patent applications to seek commercial exclusivity for SENS-401 until 2036. Sensorion has decided to select SENS-401, instead of 218, as…

news

Almirall SA Announces positive results from the phase III trial showing efficacy of dimethyl fumarate, a new systemic oral drug for patients with chronic plaque psoriasis. To present the results on Sep. 29 at the dermatology congress in Vienna.   Source : reuters.com

news

GSK and Oncodesign have signed an agreement for Oncodesign to acquire the François Hyafil Research Centre located in Villebon-sur-Yvette (Essonne) from GSK, part of the Paris Saclay innovation cluster, including transfer of the team of highly qualified drug discovery staff located at the site (anticipated to be 57 employees). Under…

news

Charles River Laboratories International, Inc. announced that it has acquired Agilux Laboratories, Inc., a Worcester, Massachusetts-based contract research organization (CRO), that provides a suite of integrated discovery small and large molecule bioanalytical services, drug metabolism and pharmacokinetic (DMPK) services, and pharmacology services. The company’s unique combination of early-stage services enhances…

news

Swiss biotech group Actelion Ltd will investigate an all-oral combination therapy for patients with relapsing multiple sclerosis (RMS), it said, calling it the first study of this approach for treating the neurological disorder. It said it would study combining ponesimod and dimethyl fumarate (Tecfidera) for patients with RMS. The POINT…

news

Cipla, ranked third in the $17-billion Indian pharmaceutical market after Sun Pharma and Abbott, is setting its eyes on reaching a billion dollar sales mark, backed by new drug launches from its own research labs and a slew of partnerships with multinational and Indian drug firms. On a moving annual…

news

Athenex Pharmaceutical Division and SunGen Pharma LLC, DBA Peterson Pharmaceuticals, a specialty pharmaceutical company located in New Jersey, today announced a joint venture agreement to launch and market 7 pharmaceutical products, both injectable and solid oral dosage, in the United States. Many of these products are therapeutically relevant to the…